Table 1. Clinical characteristics of Japanese patients with dyslipidemia.
| All patients (n = 104) |
Patients not taking LDL-C lowering drugs (n = 59) |
Patients taking LDL-C lowering drugs (n = 45) |
p value | |
|---|---|---|---|---|
| Age (years) | 53 ± 8 | 50 ± 9 | 57 ± 6 | < 0.001 |
| Men / Women | 51 / 53 | 33 / 26 | 18 / 27 | 0.107 |
| Prescribed lipid-lowering drug | 59 (56.7) | 14 (23.7) | 45 (100.0) | < 0.001 |
| Statin | 40 (38.5) | 0 (0.0) | 40 (88.9) | — |
| Cholesterol absorption inhibitor | 11 (10.6) | 0 (0.0) | 11 (24.4) | — |
| Probucol | 2 (1.9) | 0 (0.0) | 2 (4.4) | — |
| Fibrate | 13 (12.5) | 11 (18.6) | 2 (4.4) | 0.030 |
| n-3 polyunsaturated fatty acid | 7 (6.7) | 4 (6.8) | 3 (6.7) | 0.649 |
| Hypertension | 48 (46.2) | 29 (49.2) | 19 (42.2) | 0.482 |
| Prescribed antihypertensive drug | 29 (27.9) | 19 (32.2) | 10 (22.2) | 0.261 |
| Diabetes | 15 (14.4) | 6 (10.2) | 9 (20.0) | 0.157 |
| Prescribed hypoglycemic drug | 10 (9.6) | 2 (3.4) | 8 (17.8) | 0.016 |
| Prescribed anti-hyperuricemic drug | 11 (10.6) | 10 (16.9) | 1 (2.2) | 0.014 |
n = 104, Values are presented as means ± standard deviations or number (%).
P values were calculated using the unpaired t-test, the chi-square test or Fisher's exact test for comparisons between patients with versus without LDL-C-lowering drug therapy.